跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CRESEMBA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CRESEMBA
Authorized
STANDARD
CRESEMBA
avir pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5127fd1483c82daa
Company
avir pharma inc.
Type
Standard
Approval Details
Approval Id
5127fd1483c82daa
Drug Approval Canada Name
CRESEMBA
Product Name
CRESEMBA
Status
Marketed
Status Date
2019-05-31
Original Market Date
2019-05-31
Din
02483998
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:14.08
Atc Original
J02AC05 ISAVUCONAZOLE
Atc Name
j 02 ac 05
Aig Number
0161030002
Company Name
avir pharma inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE)
200 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5127fd1483c82daa
Type
Standard
Back to Health Canada Approvals